Do you want an extra edge in your weight loss battle? According to Tim Ferriss, author of the “4 Hour Body”, Cissus quadrangularis is an X factor in weight loss.
Just in-case, like me, you had never heard of this, here is a bit of science
The effect of Cissus quadrangularis (CQR-300) and a Cissus formulation (CORE) on obesity and obesity-induced oxidative stress
Julius E Oben,corresponding author1 Damaris Mandob Enyegue,1 Gilles I Fomekong,1 Yves B Soukontoua, and Gabriel A Agbor1,2
Obesity is generally linked to complications in lipid metabolism and oxidative stress. The aim of this study was to compare the effect of a proprietary extract of Cissus quadrangularis (CQR-300) to that of a proprietary formulation containing CQR-300 (CORE) on weight, blood lipids, and oxidative stress in overweight and obese people.
Both CQR-300 and CORE also brought about significant reductions in weight, body fat, total cholesterol, LDL-cholesterol, triglycerides, and fasting blood glucose levels over the respective study periods. These changes were accompanied by a significant increase in HDL-cholesterol levels, plasma 5-HT, and creatinine.
The incidence of obesity in adults as well as children is on an increase globally. Once considered a problem of developed countries, this global epidemic also affects developing countries. Coupled to this epidemic are obesity-related complications such as cardiovascular disease, stroke, depression, and Type-2 diabetes, which are spreading rapidly across poor and middle-income countries, where infectious diseases and malnutrition have previously overshadowed such illnesses . Obesity is a principal causative factor of metabolic syndrome [2-6]. The coexistence of these metabolic syndromes (hyperglycemia, dyslipidemia, and hypertension in the same individual) is a growing medical problem in industrialized countries [6-9]. It has been reported that obesity may induce systemic oxidative stress and that increased oxidative stress in accumulated fat is associated with dysregulation of adipocytokines and development of metabolic syndrome . Oxidative stress has been shown to be involved in the process of atherogenesis , ischemic heart disease , obesity , metabolic syndrome or syndrome X, diabetes [12,13], as well as in immunodeficiency . The stability of tissues against oxidative stress is however enhanced by antioxidant compounds, which could be present in the diet . Antioxidants have also been shown to be very effective in inhibiting the oxidation of LDL and scavenging of free radicals and reactive oxygen species in vitro [16-20]. These compounds are present in fruits and vegetables, which contain natural antioxidants, and are known to delay the onset of atherogenesis. Cissus quadrangularis (Linn) has been used by common folk in India for promoting the fracture healing process. It has been prescribed in Ayurveda as an alterative, anthelmintic, dyspeptic, digestive, tonic, analgesic in eye and ear diseases, and in the treatment of irregular menstruation and asthma. In Cameroon, the whole plant is used in oral re-hydration, while the leaf, stem, and root extracts of this plant are important in the management of various ailments. Earlier works on Cissus quadrangularis report its effectiveness on the management of obesity and complications associated with metabolic syndrome , as well as its antioxidant and free radical scavenging activity in vitro [22,23].
Both preparations brought about a significantly greater weight loss than a placebo during the study period in obese individuals. This was accompanied by a significant improvement in the lipid profiles, blood sugar profiles, and serotonin profiles of study participants. They could have additional properties as antioxidants against oxidative stress in obese individuals. Thus, CQR-300 as well as CORE possesses antioxidant and free radical scavenging properties that could have applications in metabolic as well as other physiological complications in which there is an increase in oxidative stress. These new findings warrant further exploration into the active phytonutrients of Cissus quadrangularis and the potential of its newly discovered weight loss and cardiovascular health benefits.
* McGill HC, Jr, C McMahan A, Herderick EE, Zieske AW, Malcom GT, Tracy RE, Strong JP. Obesity Accelerates the Progression of Coronary Atherosclerosis in Young Men. Circulation. 2002. p. 105.http://www.circulationaha.org *
Montague CT, O’Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes. 2000;49:883–888. [PubMed]
* Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: Contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci. 1999;892:146–154. doi: 10.1111/j.1749-6632.1999.tb07793.x. [PubMed] [Cross Ref]
* Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell. 2001;104:531–543. doi: 10.1016/S0092-8674(01)00240-9. [PubMed] [Cross Ref]
* Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106:473–481. [PMC free article] [PubMed]
* Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114:1752–1761. doi: 10.1172/JCI200421625. [PMC free article] [PubMed] [Cross Ref]
* Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356–359. doi: 10.1001/jama.287.3.356. [PubMed] [Cross Ref]
* Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen M, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–689. [PubMed]
* Grundy SM, Brewer HB, Cleeman JI, Smith S, Lefant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–438. doi: 10.1161/01.CIR.0000111245.75752.C6. [PubMed] [Cross Ref]
* Brown Rk, Kelly FG. Evidence for increased oxidative damage in patients with cystic fibrosis. Paediatr Res. 1994;36:487–93.
* Gutteridge JM, Swain J. Lipoprotein oxidation: the ‘fruit and vegetable gradient’ and heart disease. Br J Biomed Sci. 1993;50:284–8. [PubMed]
* Mustafa A, David E, Ksonen Laa. Diabetes, oxidative stress and physical exercise. Journal sports Sc Med. 2002;1:1–14.
* Lean M, Burns J. Tentatives pharmacologiques et nutritionnelles pour corriger le stress oxydant. Flammarion, medecine science journée de diabetologie. 2001. pp. 87–96.
* Ngondi JL, Oben J, Musoro FD, Etame SLH, Mbanya D. The effect of different combination therapies on oxidative stress markers in HIV infected patients in Cameroon. Aids Research and Therapy. 2006;3:19. doi: 10.1186/1742-6405-3-19. [PMC free article] [PubMed] [Cross Ref]
* Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Eng J Med. 1989;320:915–924
. * Frankel EN, Waterhouse AL, TeissedreSpt PL. Principal Phenolic Phytochemicals in Selected California Wines and Their Antioxidant Activity in Inhibiting Oxidation of Human Low-Density Lipoproteins. J Agric Food Chem. 1995;43:890–894. doi: 10.1021/jf00052a008. [Cross Ref]
* Kanner Jb, Frankel JE, Granit RBG, Kinsellatss JE. Natural Antioxidants in Grapes and Wines. J Agric Food Chem. 1994;42:64–69. doi: 10.1021/jf00037a010. [Cross Ref]
* Teissedre PL, Frankel EN, Waterhouse AL, Peleg H, German JB. Inhibition of in vitro human LDL oxidation by phenolic antioxidants from grapes and wines. J Sci Food Agric. 1996;70:55–61. doi: 10.1002/(SICI)1097-0010(199601)70:1<55::AID-JSFA471>3.0.CO;2-X. [Cross Ref]
* Gabriel AgborA, Oben JuliusE, Ngogang JeanneY, Xinxing Cai, Vinson JoeA. Antioxidant Capacity of Some Herbs/spices from Cameroon. A Comparative study of two Methods. J Agri and Food Chem. 2005;53:6819–6824. doi: 10.1021/jf050445c. [Cross Ref]
* Gabriel AgborA, Vinson JoeA, Oben JuliusE, Ngogang JeanneY. comparative study of the in vitro antioxidant activity of white and black pepper. Nutr Res.
* Oben J, Kuate D, Agbor G, Momo C, Talla X. The use of a cissus quadrangularis formulation in the management of weight loss and metabolic syndrome. Lipids in Health and Disease. 2006;5:24. doi: 10.1186/1476-511X-5-24. [PMC free article] [PubMed] [Cross Ref]
* Gabriel AgborA, Dieudonne Kuate, Oben E, Julius E. Medicinal plants can be good source of antioxidant: Case study of Cameroon. Pak J Biol Sci. 2006.
* Mallika J, Shyamala CSD. In vitro and In vivo evaluation of free radical scavenging potential of Cissus quadrangularis. Afri J of Biomed Res. 2005;8:95–99.
* Mehta M, Kaur N, Bhutani K. Determination of marker constituents from Cissus quadrangularis Linn and their quantitation by HPTLC and HPLC. Phytochem Anal. 2001;12:91–105. doi: 10.1002/pca.569. [PubMed] [Cross Ref]
* Jakikasem S, Limsiriwong P, Kajsongkarm T, Sontorntanasart T. Phytochemical study of cissus quadrangularis. Thai J Pharm Sci. 2000;24:25.
* Chidambara Murthy KN, Vanitha A, Mahadeva Swamy M, Ravishankar GA. Antioxidant and antimicrobial activity of cissus quadrangularis L. Journal of Medicinal Foods. 2003;6:99–105. doi: 10.1089/109662003322233495. [Cross Ref]
* Chopra SS, Patel MR, Gupta LP, Datta IC. Studies on Cissus quadrangularis in experimental fracture Repair: Effect on Chemical Parameters in Blood. Ind J Med Res. 1975;63:6.
* Singleton VL, Orthofer R, Lamuela-Raventòs RM. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Methods Enzymol. 1999;299:152–178.
* Benzie IFF, Strain JJ. The Ferric Reducing Ability of Plasma (FRAP) as a measure of antioxidant power: The FRAP assay. Anal Biochem. 1996;239:70–76. doi: 10.1006/abio.1996.0292. [PubMed] [Cross Ref]
* Yen GC, Duh PD. Scavenging effect of methanolic extracts of peanut hulls on free-radical and active oxygen species. J Agri and Food Chem. 1994;42:629–632. doi: 10.1021/jf00039a005. [Cross Ref]
* Okhawa H, Ohishi N, Yagi K. Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Annals Biochemistry. 1979;95:351–358. doi: 10.1016/0003-2697(79)90738-3. [Cross Ref]
* Levine RL, Garland D, Oliver CN. The determination of carbonyl content in oxidatively mordified proteins. Methods in Enzymology. 1990;186:484–477.
* Bartels H, Boemer M, Heirli C. Serum creatinine determination without deproteinization. Clin Chim Acta. 1972;37:193–197. doi: 10.1016/0009-8981(72)90432-9. [PubMed] [Cross Ref]
* Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochemical Medicine. 1976;15:212–216. doi: 10.1016/0006-2944(76)90049-1. [PubMed] [Cross Ref]
* SPSS for Windows, Rel. 11.0.1. Chicago: SPSS Inc; 2001
* Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813–820. doi: 10.1038/414813a. [PubMed] [Cross Ref]
* Smith IG, Goulder MA. Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity. J Fam Pract. 2001;50:505–512. [PubMed]
* Kelly DE, Bray GA, Pi-Sunyer FX, Klein S, Hill J, Miles J, Hollander P. Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated Type 2 diabetes. Diabetes Care. 2002;25:1033–1041. [PubMed]
* Yesilbursa D, Serdar Z, Serdar A, Sarac M, Jale C. Lipid peroxides in obese patients and effects of weight loss with orlistat on lipid peroxides levels. International Journal of Obesity. 2005;29:142–145. doi: 10.1038/sj.ijo.0802794. [PubMed] [Cross Ref]
* Pietrobelli A, Lee RC, Capristo E, Deckelbaum RJ, Heymsfield SB. An independent, inverse association of high-density-lipoprotein-cholesterol concentration with nonadipose body mass. Am J Clin Nutr. 1999;69:614–620. [PubMed] *
Knuiman JT, West CE, Burema J. Serum total and high density lipoprotein cholesterol concentrations and body mass index in adult men in 13 countries. Am J Epidemiol. 1982;116:631–642. [PubMed]
* Griffin BA. Lipoprotein and atherogenicity: An overview of current mechanisms. Proceedings of the Nutrition Society. 1999;58:163–169. doi: 10.1079/PNS19990022. [PubMed] [Cross Ref]
* World Health Organisation Guidelines-International Society of Hypertension Mild Hypertension Liaison Committee World Health Organisation -International Society of Hypertension guidelines for the management of hypertension. J Hypertens. 1999;17:151–183. [PubMed]
* Nelson A, Day R, Glickman-Weiss E, Hegstad M, Sampson B. Creatine supplementation raises anaerobic threshold. FASEB Journal. 1997;11:A589. (Abstract)
* Rockwell JA, Rankin JW, Toderico B. Creatine supplementation affects muscle creatine during energy restriction. Med Sci Sports Exer. 2001;33:61–8.